ArticleVaccines2022

New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.

Andrea Alberti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.